Alto Neuroscience

Alto Neuroscience Inc. received an additional $25 million in equity investment by Alpha Wave Ventures, bringing total Series B raised funding to approximately $60 million and total equity capital raised to approximately $100 million since its foundation in 2019, plus a recently...

Psychedelics-focused mental health company Novamind Inc. (CSE:NM) (OTCQB: NVMDF) (FSE: HN2) reported its financial results for the three and six months ended December 31, 2021. “We’re pleased to report record high revenue this quarter driven by continued revenue growth from existing and...